Linked Life Data

20889882

Source:http://linkedlifedata.com/resource/pubmed/id/20889882

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20889882rdf:typepubmed:Citationlld:pubmed
pubmed-article:20889882lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0021270lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0728836lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0042963lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:20889882lifeskim:mentionsumls-concept:C0936150lld:lifeskim
pubmed-article:20889882pubmed:issue4lld:pubmed
pubmed-article:20889882pubmed:dateCreated2010-10-4lld:pubmed
pubmed-article:20889882pubmed:abstractTextArtemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are highly efficacious antimalarial therapies in Africa. However, there are limited data regarding the tolerability of these drugs in young children. We used data from a randomized control trial in rural Uganda to compare the risk of early vomiting (within one hour of dosing) for children 6-24 months of age randomized to receive DP (n = 240) or AL (n = 228) for treatment of uncomplicated malaria. Overall, DP was associated with a higher risk of early vomiting than AL (15.1% versus 7.1%; P = 0.007). The increased risk of early vomiting with DP was only present among breastfeeding children (relative risk [RR] = 3.35, P = 0.001) compared with children who were not breastfeeding (RR = 1.03, P = 0.94). Age less than 18 months was a risk factor for early vomiting independent of treatment (RR = 3.27, P = 0.02). Our findings indicate that AL may be better tolerated than DP among young breastfeeding children treated for uncomplicated malaria.lld:pubmed
pubmed-article:20889882pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:languageenglld:pubmed
pubmed-article:20889882pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20889882pubmed:statusMEDLINElld:pubmed
pubmed-article:20889882pubmed:monthOctlld:pubmed
pubmed-article:20889882pubmed:issn1476-1645lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:DorseyGrantGlld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:KamyaMoses...lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:TapperoJordan...lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:CreekDarrenDlld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:SandisonTaylo...lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:ArinaitweEmma...lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:WanziraHumphr...lld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:KakuruAbelAlld:pubmed
pubmed-article:20889882pubmed:authorpubmed-author:BigiraVictorVlld:pubmed
pubmed-article:20889882pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20889882pubmed:volume83lld:pubmed
pubmed-article:20889882pubmed:ownerNLMlld:pubmed
pubmed-article:20889882pubmed:authorsCompleteYlld:pubmed
pubmed-article:20889882pubmed:pagination873-5lld:pubmed
pubmed-article:20889882pubmed:dateRevised2011-10-5lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:meshHeadingpubmed-meshheading:20889882...lld:pubmed
pubmed-article:20889882pubmed:year2010lld:pubmed
pubmed-article:20889882pubmed:articleTitleIncreased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.lld:pubmed
pubmed-article:20889882pubmed:affiliationDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA. darrencreek@gmail.comlld:pubmed
pubmed-article:20889882pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20889882pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:20889882pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20889882pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20889882pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed